Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

aXichem

1.33 SEK

+2.71 %

Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.71 %
-34.57 %
-35.52 %
-45.52 %
-46.83 %
-3.98 %
-89.61 %
-96.62 %
-92.10 %

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.

Read more
Market cap
89.52M SEK
Turnover
46.03K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26/2
2026

Annual report '25

21/5
2026

Interim report Q1'26

17/6
2026

General meeting '26

All
Press releases
3rd party
ShowingAll content types
Regulatory press releaseyesterday

aXichem AB (publ), Bokslutskommuniké, januari - december 2025

aXichem
Regulatory press releaseyesterday

aXichem AB (publ), Year End Report, January - December 2025

aXichem
Press release2/16/2026, 12:30 PM

aXichem AB: aXichems VD Torsten Helsing presenterar rapport för fjärde kvartalet 2025 i en direktsänd webbkonferens

aXichem

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/16/2026, 12:30 PM

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the Fourth Quarter 2025 in a Live Web Conference

aXichem
Press release2/13/2026, 8:00 AM

aXichem AB: aXichem publishes information memorandum and initiates subscription period

aXichem
Press release2/13/2026, 8:00 AM

aXichem AB: aXichem offentliggör informationsmemorandum och inleder teckningsperiod

aXichem
Regulatory press release2/3/2026, 9:00 PM

aXichem AB: aXichem carries out a rights issue of units of approximately SEK 11 million

aXichem
Regulatory press release2/3/2026, 9:00 PM

aXichem AB: aXichem genomför företrädesemission av units om cirka 11 MSEK

aXichem
Press release1/29/2026, 7:30 AM

aXichem AB: aXichem comments request from EFSA regarding the company's Feed Additive application in EU for phenylcapsaicin

aXichem
Press release1/29/2026, 7:30 AM

aXichem AB: aXichem kommenterar begäran från EFSA rörande bolagets ansökan om godkännande som fodertillsats för phenylcapsaicin i EU

aXichem
Press release1/20/2026, 11:30 AM

aXichem AB: aXichem updates status regarding the company's Feed Additive application in EU for phenylcapsaicin

aXichem
Press release1/20/2026, 11:30 AM

aXichem AB: aXichem uppdaterar statusen gällande företagets ansökan om godkännande som fodertillsats för phenylcapsaicin i EU

aXichem
Press release1/15/2026, 10:00 AM

aXichem AB: aXichem Announces Publication of CrossFit Study in Leading Sports Journal - Validates aXivite as a High-Intensity Performance Supplement

aXichem
Press release1/15/2026, 10:00 AM

aXichem AB: aXichems studie inom CrossFit publicerad i ledande vetenskaplig tidskrift för sport - bekräftar aXivite som prestationshöjande tillskott vid högintensiv träning

aXichem
Third party research12/9/2025, 6:21 AM

aXichem: Nytt avrop från Chr. Olesen - VH Corp

* Ny levereans till Chr. Olesen inom ramen för avropsordern * Ordern motsvarar cirka 2,6 MSEK * Kort frågestund med vd Torsten Helsing aXichem meddelade nyligen en andra leverans av aXiphen till sin leverantör i Brasilien, Chr. Olesen. Volymen motsvarar...

aXichem
Press release12/8/2025, 3:44 PM

Västra Hamnen Market Focus: aXichem: Nytt avrop från Chr. Olesen

aXichem
Press release12/8/2025, 7:30 AM

aXichem AB: aXichem genomför ännu en avropsleverans av aXiphen till Chr. Olesen i Brasilien inom ramen för tidigare order

aXichem
Press release12/8/2025, 7:30 AM

aXichem AB: aXichem carries out another call-off delivery of aXiphen to Chr. Olesen in Brazil within the framework of previous order

aXichem
Third party research12/1/2025, 11:20 AM

aXichem: Behöver hetta till i Brasilien - VH Corp

* aXivite-order från Spanien * Ansökan om fast-track registrering i Brasilien * Vi behåller det motiverade värdet om 4,26 SEK per aktie För Q3 2025 rapporterade aXichem en försäljning om 4,6 MSEK vilket betydligt något lägre än våra högt ställda förv...

aXichem
Press release12/1/2025, 11:00 AM

Västra Hamnen Market Focus: aXichem: Behöver hetta till i Brasilien

aXichem
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.